CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

Pharmaceutical Technology
Original article

Cellares and Papillon partner for PPL-001 manufacturing automation

PartnershipPPL-001Positive
AI Analysis

Summary

Cellares and Papillon Therapeutics partnered to automate the manufacturing of PPL-001, an investigational therapy for Friedreich's Ataxia, a rare inherited neurodegenerative disorder.

Importance:5/10
Sentiment:
0.30
manufacturingautomationpartnershiprare diseaseneurodegenerative

Read the original article

Published by Pharmaceutical Technology on July 22, 2026 8:49 AM

Read Original